期刊
MOLECULAR PSYCHIATRY
卷 28, 期 3, 页码 1112-1127出版社
SPRINGERNATURE
DOI: 10.1038/s41380-022-01921-z
关键词
-
This study investigates the DNA methylation in the frontal cortex of individuals with Williams syndrome (WS) and reveals disruption in the methylome compared to typically developed controls. These differentially methylated sites are predominantly located in introns and intergenic loci and are highly enriched around binding sites for transcription factors related to neuronal development, plasticity, and cognition. The study also identifies abnormal methylation patterns in neurons and oligodendrocytes, as well as impaired neuron-glia interactions in WS. Furthermore, the comparison of methylation profiles from blood samples suggests putative targets associated with WS and other associated pathologies.
Williams syndrome (WS) is a neurodevelopmental disorder caused by a heterozygous micro-deletion in the WS critical region (WSCR) and is characterized by hyper-sociability and neurocognitive abnormalities. Nonetheless, whether and to what extent WSCR deletion leads to epigenetic modifications in the brain and induces pathological outcomes remains largely unknown. By examining DNA methylation in frontal cortex, we revealed genome-wide disruption in the methylome of individuals with WS, as compared to typically developed (TD) controls. Surprisingly, differentially methylated sites were predominantly annotated as introns and intergenic loci and were found to be highly enriched around binding sites for transcription factors that regulate neuronal development, plasticity and cognition. Moreover, by utilizing enhancer-promoter interactome data, we confirmed that most of these loci function as active enhancers in the human brain or as target genes of transcriptional networks associated with myelination, oligodendrocyte (OL) differentiation, cognition and social behavior. Cell type-specific methylation analysis revealed aberrant patterns in the methylation of active enhancers in neurons and OLs, and important neuron-glia interactions that might be impaired in individuals with WS. Finally, comparison of methylation profiles from blood samples of individuals with WS and healthy controls, along with other data collected in this study, identified putative targets of endophenotypes associated with WS, which can be used to define brain-risk loci for WS outside the WSCR locus, as well as for other associated pathologies. In conclusion, our study illuminates the brain methylome landscape of individuals with WS and sheds light on how these aberrations might be involved in social behavior and physiological abnormalities. By extension, these results may lead to better diagnostics and more refined therapeutic targets for WS.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据